Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Broncus Medical

125 Nicholson Lane
San Jose, CA 95134
Website Company Summary Management Team

President/COO/Operations: Henky Wibobo (3/31/2006)
Finance: Bin Tang (1/31/2016) ; Dean MacIntosh (9/30/2007)
Technology: Tom Keast (1998)
Sales/Marketing: Todd Comell

Outside board: (May no longer be on the board) Juliet Tammenoms Bakker (Longitude Capital Managing Director);  Beat Merz (Ares Life Sciences);  Michael Zhao (Broncus Medical Chairman);  James Fitzsimmons (Scout Medical)
Advisory board: Lester Lien (Pac-Link BioVentures Investment partner);  Marc-Henri Galletti (Longitude Capital Managing Director)

Business description: Broncus Medical, Inc. is dedicated to the development of diagnostic and therapeutic technology for lung disease. Founded in 2012, the company’s primary technology platforms focus on the diagnosis of lung cancer and the treatment of emphysema. Its lung cancer portfolio includes the Archimedes™ System, Archimedes™ Planner, LungPoint® Virtual Bronchoscopic Navigation (VBN) System, LungPoint® Planner and FleXNeedle®.

Rounds: 8
Recent Fundings: Jun 2018   Dec 2008
Capital raised: 126.0M
Last Round: 15.0M
Ownership: Private  
VCs include: Charter Life SciencesMenlo VenturesSightLine Partners;  Biomedical Sciences Investment Fund;  NSE Ventures;  DB Capital Partners;  PGP/Hunter Partners;  Saratoga Ventures;  Upper Lake Growth Capital;  Abingworth Bioventures;  Pequot Ventures (FirstMark Capital);  Oakwood Medical Investors;  HBM Bioventures;  Piper Jaffray Ventures;  Bio-Star;  Saints CapitalBio*One Capital;  Rockport Ventures;  Japan Asia Investment Co.;  Ares Life Sciences
Corporate investors: Intuitive Surgical Boston ScientificFenwickAndWestCooley Godward Kronish;  Pacific Life Insurance Company;  Mitsui Private Equity;  Pac-Link Management

Last Tweets


Last Mentions

Record updated: Jun 2022
Sector: Medical
Year Founded: 1997
Headcount: 51-75 as of Jun 2022
Rounds: 8
Recent Fundings: Jun 2018   Dec 2008
Capital Raised: 126.0M
Last Round: 15.0M
Ownership: Private